Yüklüyor......
A single-institution experience with bevacizumab in the treatment of metastatic colorectal cancer and in conjunction with liver resection
BACKGROUND: Bevacizumab is active in the treatment of metastatic colorectal cancer (mCRC). However, efficacy of bevacizumab has predominantly been evaluated on selected patients with relatively good performance status and minor comorbidities. We evaluated the efficacy and safety of bevacizumab in un...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4085307/ https://ncbi.nlm.nih.gov/pubmed/25061319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S63739 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|